Skip to main content
Bulletin of the National Research Centre
Download PDF

A new aspect on the correlation of ten SNPs in MIR and their target genes in dopaminergic pathways in schizophrenia

Bulletin of the National Research Centre volume 46, Article number: 51 (2022) Cite this article

Abstract

Background

Schizophrenia (SCZ) is a severe mental disorder in which people interpret reality abnormally. Different studies indicated a complex polygenic control over SCZ. In the present study, we investigated the potential correlation between ten SNPs among MicroRNA (MIR) and their target genes; rs369770942, rs143525573, rs200982455, rs530404895, rs753764536, rs374732351, rs4680, rs165599, rs340597269, and rs10759, and schizophrenia in the Iranian population.

Results

The results revealed that the T allele in rs200982455 increased the risk factor by 3.19 times. We obtained a significant association between rs165599 and schizophrenia in codominant, dominant, and overdominant inheritance models (P = 0.016, P = 0.01, P = 0.004, respectively). Moreover, the risk of schizophrenia increased in the presence of the G allele in rs165599 up to 2.12, 2.35, and 2.28 times, respectively. The A allele in rs10759 increased the risk factor up to 1.05 times.

Conclusion

Our finding showed that some of the studied SNPs within the genes and MIRs involved in the dopaminergic pathway may consider as a biomarker in the diagnostic patterns in Schizophrenia.

Highlights

  • The association between SNPs in COMT gene and schizophrenia

  • The correlation of SNPs in target genes and MIRs in the dopaminergic pathway

Background

Schizophrenia (SCZ) is a mental disorder with 1% lifetime prevalence. Different genes and processes have been considered as potential causes of schizophrenia. For instance, malfunctioning dopamine receptors, which play an essential role in dopaminergic pathways, are one of the causes of developing schizophrenia (Kuncara 2019; Liu et al. 2014). The level of dopamine content is significantly higher in patients with schizophrenia than that of healthy individuals (Grace 2016; Kesby et al. 2018). The genetics of SCZ is considered a complex disease without a specified inheritance model. A multi-locus model has been proposed to indicate the pattern of heritability in this complicated disorder. The model illuminates that a composition of various genetic facets is involved in schizophrenia (Risch 1990). Thereby, the development of SCZ might be affected by more than one locus and consists of a complex polygenic interaction (Estrada et al. 2011; Raznahan et al. 2011; Singh et al. 2012). Dopamine receptors, such as the Dopamine D1 family (DRD1 and DRD5 receptors) as well as the Dopamine D2 family (including DRD2, -DRD4 receptors), act as G-protein coupled receptors (Funahashi et al. 2019; Kuncara 2019; Liu et al. 2014; Poorshekar et al. 2019). The regulator of G-protein signaling 4 (RGS4) is another candidate gene for schizophrenia, which is known to have a significant role in brain development stages, such as neuronal differentiation and the formation of new axons (Schwarz 2018; Chowdari et al. 2008; Ding et al. 2016; Paspalas et al. 2009).

The Neuregulin-1 gene (NRG-1), located on chromosome 8p13, is also considered a potential gene for schizophrenia (Zhang et al. 2008). Alternations in the NRG1 function expressed in dopaminergic neurons are associated with schizophrenia (Ledonne et al. 2015). Catechol-O-methyltransferase (COMT) is an enzyme that has a significant role in dopamine catabolism and has been reported to be associated with schizophrenia (Gozukara Bag 2018; Morozova et al. 2019). The rs4680 (Val158Met polymorphism) and rs165599 in the COMT gene are two single-nucleotide polymorphisms, potentially candidates related to schizophrenia (Morozova et al. 2019; Gozukara Bag 2018).

The association between many human diseases and microRNAs have been shown (Paul et al. 2018, 2019). MicroRNAs are noncoding RNAs, which bind to 3′ regions (3′UTRs) of the target mRNAs to regulate their expression. Some variants in 3′ UTR of the genes may increase the risk of diseases due to altering microRNAs' binding to the target mRNAs. The miR-124 is one of the important miRNAs which act in the development of the brain. The RGS4 gene is the target for this miR (Dwivedi 2017). Similarly, miR-326 positively regulates the expression of the DRD2 gene, so it affects the dopamine system and causes the development of schizophrenia (Shi et al. 2014; Zhang et al. 2015). MiR-125a-3p, a member of the miR-125a family, is derived from the 3′-end of pre-miR-125a. Based on laboratory evidence and using Bioinformatics software, the NRG1 gene is predicted as a target gene for miR-125a-3p, and it has been determined that the 3′UTR region of the NRG1 gene has highly protected regions that may be considered as a Connection site for miR-125a-3p (Qi and David 2012).

Concerning the association of these genes with schizophrenia, no similar studies have investigated the correlation between SNPs located in these genes with schizophrenia in the Iranian population. rs369770942, rs143525573, rs200982455, rs530404895, rs753764536, rs374732351, and rs340597269 needed to be studied, not only because of their remarkable genomic locations but were also explored neither Iran nor across the world. Despite their probable effect on dopaminergic pathways and brain development stages, which are supposed to play a crucial role in SCZ, their correlation with the disorder was entirely neglected to be explored up to the current study. We faced either inadequate or inconsistent results due to the correlation studies between rs4680, rs10759, rs165599, and schizophrenia. Shifman claimed that the C-GG haplotype for the SNPs rs737865-rs4680-rs165599 was correlated with schizophrenia in Ashkenazi Jews (Shifman et al. 2002). Additionally, rs10759 (RGS4) raised the risk of schizophrenia by miRNA altering the binding of miRNAs to their targets, influencing susceptibility to schizophrenia (Gong et al. 2013), although Williams and Nunokawa reported that rs4680 and rs165599 might not be associated with schizophrenia (Williams et al. 2005; Nunokawa et al. 2007). Therefore, in the current research, we aimed to study (1) Correlation between ten SNPs; rs369770942, rs143525573, rs200982455, rs530404895, rs753764536, rs374732351, rs4680, rs165599, rs340597269, and rs10759 in MIRs and their target genes, and (2) Investigating the potential association of these SNPs with schizophrenia in the Iranian population.

We opted for five SNPs situated in 3′UTR of NRG1, DRD2, COMT, and RGS4 genes for this study. They are presumed to be associated with schizophrenia (Cui and Jiang 2012; Luykx et al. 2017; Shariati et al. 2011; Shifman et al. 2002).

Also, the other five SNPs we chose, which are located in MIR-125-a, MIR-326, and MIR-124 genes, are supposed to be related to either adjustment of NRG1, DRD2, COMT, and RGS4 genes or schizophrenia (Camkurt et al. 2016; Gong et al. 2013; Shi et al. 2014).

Methods

SNP data retrieval

NCBI dbSNP is the most extensive SNP database; thus, the ten SNPs were chosen and retrieved from this database. The criteria for choosing these SNPs were their susceptibility to being digested with restriction enzymes in desired locations in the 3′UTR region of the target genes and the 5′UTR region of the MicroRNA genes. The workflow of choosing SNPs is shown in Fig. 1. PANSS (Positive and negative syndrome scale): a 30-item rating scale with three subscales which evaluates positive and negative symptoms and global psychopathology. Patients can rate each item from 1 to 7, so the minimum score is 30 and the maximum is 210. The reliability and validity of the scale have been approved and showed good psychometric properties (Kay et al. 1988), and it has been used widely in patients with schizophrenia in Iran (Chaychi et al. 2015; Ghanbari Jolfaei et al. 2012; Hatami et al. 2017). In the present study, 102 patients with schizophrenia (67 males and 35 females) referred to the psychiatric ward of Imam Hossein Educational Hospital and 506 Artesh hospital, Tehran, Iran, were selected. For this purpose, the subjects' medical records were first studied, and their details were compared to this research's conditions. According to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, Text Revision (DSM-IV-TR), patient entry requirements for this study were verified using research tools, including demographic questionnaire (age, gender, and treatment response), the positive and negative syndrome scale test (PANSS), and clinical interview. Finally, the disorder was confirmed by a psychiatrist. The criteria for excluding patients from the study included schizoaffective or any other psychiatric disorder, mental retardation, drug, and stimuli abuse. In order to observance ethical considerations, each patient and their supervisor received written consent. On the other hand, 100 control subjects (62 males and 38 females) were selected from healthy individuals whose mental health was confirmed by clinical interview.

Fig. 1
figure 1

The chart of choosing desired SNPs located in the 3′region of the target genes and the 5′UTR region of the MicroRNA genes

Full size image

The conditions for selecting control subjects included lack of schizophrenia, severe psychiatric disorder or other physical illness, lack of family history of severe mental disorders, and non-use of drugs and stimuli. The PANSS also was done for controls.

This research has an ethical code IR.IAU.SRB.REC.1396.43. The demographic characters were questioned, including sex, age, education, ethnics, job, alcohol and drug usage, relative responses to treatment, and family history.

Genomic DNA extraction

The peripheral blood sample was collected and transferred to the laboratory and stored at − 70 °C for further study. Genomic DNA was extracted by using an optimized salting-out method and then stored at − 20 °C. The quantity and quality of genomic DNA were examined by a 0.8% agarose gel electrophoresis and spectrophotometer.

Genotyping

In order to determine the genotypes, polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) and PCR-sequencing were performed. Eight pairs of specific primers (which were designed by Primer3 and Gene Runner software) were used to amplify MIRs and their 3′UTR region target genes (Table 1).

Table 1 The primers, their sequences, Tm, product size used for PCR
Full size table

PCR reactions for studied regions of the genome were performed in 25 μl containing 50 ng template DNA, 1X PCR buffer, 200 µM dNTP, 1.5 mM MgCl2, 0.4 µM of each of the forward and reverse primers, 1U Taq DNA polymerase (Cinnagen, Tehran, Iran).

PCR thermal program (Bio-Rad, USA) was as follows: initial denaturation at 94 °C for 5 min, followed by 40 cycles in three steps: 30 s at 94 °C, the annealing step for each pair of primers based on Table 1, 40 s at 72 °C, and final extension at 72 °C for 7 min. The PCR products were loaded on a %1.5 agarose gel and visualized by GelRed™ Nucleic Acid Gel Staining. Fragment size was measured by using a 100-bp molecular size ladder (Vivantis, Malaysia).

For digestion PCR products, restriction enzymes were used for each SNP (Table 1). The digested products were run on 2% agarose gel electrophoresis. For MIR326 SNPs, RGS1 (rs10759), as well as COMT (rs165599) (Table 1), the PCR products were sequenced. For confirming genotypes in PCR–RFLP, PCR products were sequenced (Pishgam Company, Tehran, Iran).

Data analysis

The crude odds ratio (COR) and 95% confidence interval (CI) indicate a potential association between genotypes and the disease. Multiple comparisons were performed to avoid false-positive results using principal component analysis (PCA) using the PAST program. Hardy–Weinberg equilibrium was estimated by using the chi-square test. We considered p-value < 0.05 to be statistically significant. Hardy–Weinberg equilibrium was estimated by using the chi-square test. We considered p-value < 0.05 to be statistically significant. Haplotype frequency of SNPs' genotypes and haplotype association between control and case samples were estimated using SNPstats software (https://www.snpstats.net/start.htm). The Holm–Bonferroni Method was used to correct the p-value LD test. For the prediction of single-nucleotide polymorphism effects on the miRNAs' second structure, we used the RNAfold MFE tool. RNA fold (http://rna.tbi.univie.ac.at/cgibin/RNAWebSuite/RNAfold.cgi) is a web-based software developed to analyze the noncoding RNAs' second structures (Lorenz et al. 2011).

Results

The demographic characters were obtained, including sex, age, education, ethnics, job, alcohol and drug usage, relative responses to treatment, and family history are provided in Additional file 1: Tables S1, S2 and S3.

The enzymatic digestion of rs369770942 (NC-000008.11) by DdeI produced two fragments with 148 bp and 652 bp size length in the presence of A allele (ancestral allele). There were three fragments with 441 bp, 211 bp, and 148 bp size length, which would be observed in the presence of the G allele (Table 2).

Table 2 Association of the ten studied polymorphisms with Schizophrenia assuming different genetic models
Full size table

The enzymatic digestion of rs143525573 (NC-000019.10) by DdeI gave rise to four fragments with 10 bp, 75 bp, 90 bp, and 359 bp size length in the presence of the G allele (ancestral allele). Conversely, we did not observe these five fragments in the presence of the A allele (Table 2).

The enzymatic digestion of rs200982455 (NC-000011.10) using DdeI identified four fragments with 17 bp, 36 bp, 43 bp, and 153 bp size length in the presence of the C allele (ancestral allele), whereas five fragments with 17 bp, 36 bp, 40 bp, 43 bp, and 113 bp size length were obtained in the presence of the T allele (Table 2).

The enzymatic digestion of rs4680 (NC-000022.11) by NlaIII produced three fragments with 242, 87, and 54 bp size length in the presence of G allele (ancestral allele), while four fragments with 242, 69, 54, and 18 bp were obtained in the existence of A allele (Table 2).

The enzymatic digestion of rs34059726 (NC-000020.11) using AseI showed one fragment with a 202 bp size length in the presence of the G allele (ancestral allele). On the other hand, two fragments with 45 bp and 157 bp size length were detected in the presence of the T allele (Table 2).

Genotyping of the other SNPs, including rs530404895 (NC-000011.10), rs753764536 (NC-000011.10), rs374732351 (NC-000011.10), rs165599 (NC-000022.11), and rs10759 (NC-000022.11) genotypes, was done by using PCR sequencing (Table 2).

The results obtained for the genotype frequencies and the inheritance models are presented in Table 2. Due to lack of heterogeneity, the assessment of p-value, OR (95% CI), and Linkage disequilibrium analysis were not performed for rs369770942, rs143525573, rs530404895, rs753764536, rs374732351, and rs4680.

A significant difference did not occur between case and control groups for rs200982455 (P = 0.28). Logistic regression indicated that the T/T genotype increased the risk factor 3.19 times.

A significant difference was detected between the case and control groups in codominant, dominant, and overdominant models for the rs165599 (P = 0.016, P = 0.01, and P = 0.004, respectively).

Logistic regression revealed that in the codominant model, the A/G genotype increased the risk factor by 2.35 times, while the G/G genotype increased the risk factor by 1.17 times.

In the dominant model, the risk factor was increased up to 2.14 times in the A/G-G/G genotypes presence. Similarly, in the recessive model, the risk factor was increased up to 0.71 times in the G/G genotype presence.

In the overdominant model, the A/G genotype increases the risk factor by 2.28 times.

A significant difference did not occur between the case and control groups for rs10759 (P = 0.89). Logistic regression revealed that the A/A genotype raised the risk factor by 1.05 times.

The PCA ordination based on 10 SNPs data showed partially differentiation between case and control samples while some samples showed admixture genotypes between two groups (Fig. 2).

Fig. 2
figure 2

PCA ordination based on ten SNP genotyping in two groups studied (blue dot: case and black dot: control samples)

Full size image

The haplotype analysis of ten SNPs indicated that the highest frequency is belonged to AGCCGGAATC haplotype (0.495, rs369770942, rs143525573, rs200982455, rs530404895, rs753764536, rs374732351, rs4680, rs165599, rs34059726, and rs10759, respectively). By considering the haplotype's OR = 1.00, the approximate risk in 95%C for AGCCGGAGTC, AGCCGGAATA, AGCCGGAGTA, and AGTCGGAATC haplotypes none of them show considerable correlation with schizophrenia [(OR (95% CI) = 1.33 (0.80–2.23) P = 0.28), (OR (95% CI) = 0.88 (0.52–1.50) P = 0.64), (OR (95% CI) = 2.03 (0.88–4.70), P = 0.1) and (OR (95% CI) = 1.15 (0.28–4.72) P = 0.84, (Table 3)].

Table 3 Haplotypes of ten SNPs studied
Full size table

Linkage disequilibrium (LD) was surveyed between three SNPs: rs200982455, rs165599, and rs10759. The analysis was based on the D and D′ value, r and associated p-value. These three SNPs of 3′UTR COMT, 3′UTR RGS4, and 3′UTR DRD2 genes showed no link together [(rs200982455- rs4680 (D value =  − 0.0021, D′ value = 0.296, R =  − 0.0314, P = 0.5304), rs200982455- rs10759 (D value =  − 0.0039, D′ value = 0.9851, R =  − 0.0704, P = 0.1594) and rs4680- rs10759 (D value =  − 0.006, D′ value = 0.0843, R =  − 0.0313, P = 0.5317)].

Discussion

Five of the ten studied SNPs are situated in 3′UTR of NRG1, DRD2, COMT, and RGS4 genes. They are presumed to be associated with schizophrenia (Cui and Jiang 2012; Luykx et al. 2017; Shariati et al. 2011; Shifman et al. 2002). Another five SNPs have been chosen, which are located in MIR-125-a, MIR-326, and MIR-124 genes. They are supposed to be related to either adjusting NRG1, DRD2, COMT, and RGS4 genes or schizophrenia (Camkurt et al. 2016; Gong et al. 2013; Shi et al. 2014).

The rs369770942, rs143525573, rs200982455, rs530404895, rs753764536, rs374732351, and rs34059726 are capable to be nominated as critical SNPs in dopaminergic pathways, because of their genomic locations. Their correlations with schizophrenia have not been reported in an Iranian population as well as other populations. We found no association between these SNPs and schizophrenia in the Iranian population, although logistic regression revealed that T/T genotype in rs200982455 increased the risk of schizophrenia up to 3.19 times.

The recessive inheritance model of rs165599 and rs10759, which have been examined in various populations, the association was not observed in the Iranian population.

The rs4680 is supposed as a significant SNP for conceiving the genetic etiology of psychiatric disorders (Taylor 2018). González-Castro declared that rs4680 is remarkably associated with schizophrenia in the allelic model in the Caucasian population (Gonzalez-Castro et al. 2016). On the other hand, the association was not observed in the Asian population in genetic models after eliminating heterogeneity. Our result showed homozygous genotype AA in all samples studied, minor allele frequency (MAF) in this SNP. We have also found no association between rs4680 and schizophrenia in the Iranian population.

The rs165599 is considered a dubious SNP for schizophrenia (Okochi et al. 2009). Reported evidence is not consistent, with regard to the correlation between rs165599 and schizophrenia.

According to a meta-analysis, which contained both case–control and family-based studies, there was no association between rs165599 and schizophrenia (Okochi et al. 2009).

Acar stated that no association was detected between rs165599 and schizophrenia (Acar et al. 2015). Meanwhile, our result showed the association in codominant, dominant, and overdominant inheritance models between rs165599 and schizophrenia in the population studied (P = 0.016, P = 0.01, P =  = 0.004 respectively).

Funke declared that the presence of a G allele in rs165599 led to an increase in the risk of psychiatric disorders, such as schizophrenia (Funke et al. 2005). We have also noticed that the presence of a G allele in codominant, dominant, and overdominant inheritance models has increased the risk factor up to 2.12, 2.35, and 2.28 times, respectively.

Polymorphisms might influence the miRNA binding to specified mRNAs and the risk of diseases in 3′ UTRs of genes. In miRNA maturation, primary miRNAs, which are transcribed from DNA sequence processed to precursor miRNA by RNA binding protein named DGCR8 and Drosha, a ribonuclease III enzyme. In the next stage, RNase III endonuclease, Dicer produces mature miRNA from the pre-miRNA, interacting with the target mRNAs to change their expression (O'Brien et al. 2018). Regulatory functions of miRNAs are dependent upon their secondary structure (Yu et al. 2018). For the formation of RNA secondary structure, the complementary base pairing of the single-stranded RNA is needed. The development of optimal two-dimensional secondary structures occurs in the minimum thermodynamic free energy known as the minimum free energy structure (MFE) (George and Thomas 2016). As shown in Table 4, the single-nucleotide polymorphisms can affect the MFE structure of desired miRNAs at a low level, but there are no shreds of evidence in desired miRNAs dysfunction since none of the variants were included in mature miRNA structures. For instance, rs10759 is situated in 3′ UTR of the RGS4 gene. The SNP is supposed to interfere with miR-124 binding to RGS4 and augments the risk of schizophrenia (Gong et al. 2013). Cui and Jiang indicated rs10769 is associated with schizophrenia by studying rs10759 in 662 persons (including 315 patients and 347 controls) (Cui and Jiang 2012). We did not find an association between rs10759 and schizophrenia in the Iranian population (P = 0.89). C/C genotype increased the risk factor up to 1.05 times in the presence of the A/A genotype as reference.

Table 4 Estimated minimum free energy (MFE) of miRNAs second structures using RNAfold
Full size table

Achieved results indicated that rs165599 genotypes in codominant, dominant, and overdominant inheritance models are associated with schizophrenia in the Iranian population. The T allele in rs200982455, G allele in rs165599, and the A allele in rs10759 must be considered the risk factor.

The present study reveals neither association between haplotypes and schizophrenia nor linkage between the three SNPs; rs200982455, rs165599, and rs10759. Although there is exclusively no report on the association between these three SNPs in other populations, we anticipate getting conflicting findings in other case–control studies. In addition to the influence of structure and stratification of different populations, the interaction between miRNAs and mRNAs should be considered a remarkable agent, significantly affecting the findings.

Convincing the patients, especially those with paranoia for completing written consent, was the limitation of this study. The expensive price of the next-generation sequencing tools for studying SNPs in the great scale, the small number of cases was the other study limitations. Also, comorbid psychiatric conditions could not be identified using the PANSS test.

Conclusions

These results are a preliminary report in the Iranian population in these SNPs. Our finding showed the significant correlation of some of the studied SNPs in genes and MIRs in the dopaminergic pathway. It may consider as a biomarker in the diagnostic pattern in schizophrenia.

However, the difference in the results of researchers’ reports stems from the influence of the structure and stratification of different populations.

Availability of data and materials

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. PANSS test and clinical interview according to DSM-IV-TR are not public because of ethical restrictions.

Abbreviations

SCZ:

Schizophrenia

SNP:

Single-nucleotide polymorphism

MIR:

MicroRNA

DRD:

Dopamine receptors D

GPCR:

G-protein-coupled receptor

NRG-1:

Neuregulin-1

COMT:

Catechol-O-methyltransferase

PANSS:

Positive and negative syndrome scale

PCR–RFLP:

Polymerase chain reaction–restriction fragment length polymorphism

COR:

Crude odds ratio

CI:

Confidence interval

LD:

Linkage disequilibrium

MAF:

Minor allele frequency

MFE:

The minimum free energy structure

References

  • Acar C, Sözen MM, Gözükara H, Orman K, Kartalcı Ş (2015) Lack of association between catechol-Omethyltransferase and schizophrenia in a Turkish population. Turk J Biochem 40:205–209

    Google Scholar 

  • Camkurt MA, Karababa F, Erdal ME, Bayazıt H, Kandemir SB, Ay ME, Kandemir H, Ay Öİ, Çiçek E, Selek S, Taşdelen B (2016) Investigation of dysregulation of several microRNAs in peripheral blood of schizophrenia patients. Clin Psychopharmacol Neurosci 14:256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chaychi I, Foroughipour M, Haghir H, Talaei A, Chaichi A (2015) Electroencephalographic characteristics of Iranian schizophrenia patients. Acta Neurol Belg 115:665–670

    Article  PubMed  Google Scholar 

  • Chowdari KV, Bamne M, Wood J, Talkowski ME, Mirnics K, Levitt P, Lewis DA, Nimgaonkar VL (2008) Linkage disequilibrium patterns and functional analysis of RGS4 polymorphisms in relation to schizophrenia. Schizophr Bull 34:118–126

    Article  PubMed  Google Scholar 

  • Cui D, Jiang K (2012) Research in China on the molecular genetics of schizophrenia. Shanghai Arch Psychiatry 24:187

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ding L, Styblo M, Drobná Z, Hegde AN (2016) Expression of the longest RGS4 splice variant in the prefrontal cortex is associated with single nucleotide polymorphisms in schizophrenia patients. Front Psychiatry 7:26

    Article  PubMed  PubMed Central  Google Scholar 

  • Dwivedi Y (2017) microRNA-124: a putative therapeutic target and biomarker for major depression. Taylor & Francis, Routledge

    Google Scholar 

  • Estrada G, Fatjo-Vilas M, Munoz MJ, Pulido G, Minano MJ, Toledo E, Illa JM, Martin M, Miralles ML, Miret S, Campanera S, Bernabeu C, Navarro ME, Fananas L (2011) Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatry Scand 123:485–492

    Article  CAS  Google Scholar 

  • Funahashi Y, Yoshino Y, Yamazaki K, Ozaki Y, Mori Y, Mori T, Ochi S, Iga JI, Ueno SI (2019) Analysis of methylation and-141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia. Psychiatry Res 278:135–140

    Article  CAS  PubMed  Google Scholar 

  • Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL, Lencz T, DeRosse P, Kane JM, Kucherlapati R (2005) COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav Brain Funct 1:19

    Article  PubMed  PubMed Central  Google Scholar 

  • George TP, Thomas T (2016) Novel approach to analyzing MFE of noncoding RNA sequences. Genomics Insights 9:41–49

    Article  PubMed  PubMed Central  Google Scholar 

  • Ghanbari Jolfaei A, Moshki P, Asgharpour M, Moshki H (2012) The Relationship between attention/vigilance and symptom severity in schizophrenic patients. Iran J Psychiatr 7:22–25

    Google Scholar 

  • Gong Y, Wu CN, Xu J, Feng G, Xing QH, Fu W, Li C, He L, Zhao XZ (2013) Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets. Eur Neuropsychopharmacol 23:1182–1189

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez-Castro TB, Hernandez-Diaz Y, Juarez-Rojop IE, Lopez-Narvaez ML, Tovilla-Zarate CA, Genis-Mendoza A, Alpuin-Reyes M (2016) The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis. Behav Brain Funct 12:29

    Article  PubMed  PubMed Central  Google Scholar 

  • Gozukara Bag HG (2018) Association between COMT gene rs165599 SNP and schizophrenia: a meta-analysis of case-control studies. Mol Genet Genomic Med 6:845–854

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Grace AA (2016) Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci 17:524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hatami M, Karamghadiri N, Mohaghegh H, Yoosefee S, Karimipoor M, Hadjighasem M, Ananloo ES (2017) Neuregulin-1 gene and schizophrenia, and its negative symptoms in an iranian population. Iran J Psychiatry Behav Sci 11:e4484

    Google Scholar 

  • Kay SR, Opler LA, Lindenmayer JP (1988) Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 23:99–110

    Article  CAS  PubMed  Google Scholar 

  • Kesby JP, Eyles DW, McGrath JJ, Scott JG (2018) Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Transl Psychiatry 8:1–12

    Article  Google Scholar 

  • Kuncara DB (2019) Polymorphism of Dopamine D2–141C Ins/Del receptor gene in paranoid schizophrenia and non schizophrenia patients of batak ethnicity in sumatera utara. Bul Farmatera 4:18–28

    Article  Google Scholar 

  • Ledonne A, Nobili A, Latagliata EC, Cavallucci V, Guatteo E, Puglisi-Allegra S, D’Amelio M, Mercuri NB (2015) Neuregulin 1 signalling modulates mGluR1 function in mesencephalic dopaminergic neurons. Mol Psychiatry 20:959–973

    Article  CAS  PubMed  Google Scholar 

  • Liu L, Fan D, Ding N, Hu Y, Cai G, Wang L, Xin L, Xia Q, Li X, Xu S, Xu J (2014) The relationship between DRD2 gene polymorphisms (C957T and C939T) and schizophrenia: a meta-analysis. Neurosci Lett 583:43–48

    Article  CAS  PubMed  Google Scholar 

  • Lorenz R, Bernhart SH, Höner zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL (2011) ViennaRNA Package 2.0. Algorithms Mol Biol 6:26

    Article  PubMed  PubMed Central  Google Scholar 

  • Luykx JJ, Broersen JL, de Leeuw M (2017) The DRD2 rs1076560 polymorphism and schizophrenia-related intermediate phenotypes: a systematic review and meta-analysis. Neurosci Biobeh Rev 74:214–224

    Article  CAS  Google Scholar 

  • Morozova A, Zorkina Y, Pavlov K, Pavlova O, Storozheva Z, Zubkov E, Zakharova N, Karpenko O, Reznik A, Chekhonin V, Kostyuk G (2019) Association of rs4680 COMT, rs6280 DRD3 and rs7322347 5HT2A with clinical features of youth-onset schizophrenia. Front Psychiatry 10:830

    Article  PubMed  PubMed Central  Google Scholar 

  • Nunokawa A, Watanabe Y, Muratake T, Kaneko N, Koizumi M, Someya T (2007) No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Neurosci Res 58:291–296

    Article  CAS  PubMed  Google Scholar 

  • O’Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (lausanne) 9:402

    Article  CAS  Google Scholar 

  • Okochi T, Ikeda M, Kishi T, Kawashima K, Kinoshita Y, Kitajima T, Yamanouchi Y, Tomita M, Inada T, Ozaki N, Iwata N (2009) Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr Res 110:140–148

    Article  PubMed  Google Scholar 

  • Paspalas CD, Selemon LD, Arnsten AFT (2009) Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex. Cereb Cortex 19:2145–2155

    Article  PubMed  PubMed Central  Google Scholar 

  • Paul P, Chakraborty A, Sarkar D, Langthasa M, Rahman M, Bari M, Singha RS, Malakar AK, Chakraborty S (2018) Interplay between miRNAs and human diseases. J Cell Physiol 233:2007–2018

    Article  CAS  PubMed  Google Scholar 

  • Paul S, Reyes PR, Garza BS, Sharma A (2019) MicroRNAs and child neuropsychiatric disorders: a brief review. Neurochem Res 45:232–240

    Article  PubMed  Google Scholar 

  • Poorshekar S, Firoozfar A, Yassini Ardekani SM, Kalantar SM (2019) Study of the association between DRD2 Gene Ser311Cys and GSTM1 gene polymorphism in schizophrenia. SSU J 27:1602–1611

    Google Scholar 

  • Qi J, David M (2012) MicroRNAs and lung cancers: from pathogenesis to clinical implications. Front Med 6:134–155

    Article  PubMed  PubMed Central  Google Scholar 

  • Raznahan A, Greenstein D, Lee Y, Long R, Clasen L, Gochman P, Addington A, Giedd JN, Rapoport JL, Gogtay N (2011) Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls. Neuroimage 57:1517–1523

    Article  CAS  PubMed  Google Scholar 

  • Risch N (1990) Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am J Hum Genet 46:242–253

    CAS  PubMed  PubMed Central  Google Scholar 

  • Schwarz E (2018) A gene-based review of RGS4 as a putative risk gene for psychiatric illness. Am J Med Genet Part B Neuropsychiatr Genet 177:267–273

    Article  Google Scholar 

  • Shariati SA, Behmanesh M, Galehdari H (2011) A study of the association between SNP8NRG241930 in the 5′End of Neuroglin 1 gene with schizophrenia in a group of Iranian patients. Cell J (yakhteh) 13:91

    CAS  Google Scholar 

  • Shi S, Leites C, He D, Schwartz D, Moy W, Shi J, Duan J (2014) MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant. J Biol Chem 289:13434–13444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shifman S, Bronstein M, Sternfeld M, Pisanté-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R (2002) A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296–1302

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Singh J, Kour K, Jayaram MB (2012) Acetylcholinesterase inhibitors for schizophrenia. Cochrane Database Syst Rev 1:CD007967

    PubMed  Google Scholar 

  • Taylor S (2018) Association between COMT Val158Met and psychiatric disorders: a comprehensive meta-analysis. Am J Med Genet B Neuropsychiatr Genet 177:199–210

    Article  CAS  PubMed  Google Scholar 

  • Williams HJ, Glaser B, Williams NM, Norton N, Zammit S, MacGregor S, Kirov GK, Owen MJ, O’Donovan MC (2005) No association between schizophrenia and polymorphisms in COMT in two large samples. Am J Psychiatry 162:1736–1738

    Article  PubMed  Google Scholar 

  • Yu H, Yan H, Wang L, Li J, Tan L, Deng W, Chen Q, Yang G, Zhang F, Lu T, Yang J, Li K, Lv L, Tan Q, Zhang H, Xiao X, Li M, Ma X, Yang F, Li L, Wang C, Li T, Zhang D, Yue W, Consortium Chinese Antipsychotics Pharmacogenomics (2018) Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study. Lancet Psychiatry 5:327–338

    Article  PubMed  Google Scholar 

  • Zhang HX, Zhao JP, Lv LX, Li WQ, Xu L, Ouyang X, Yuan ZQ, Huang JS (2008) Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia. Neurosci Lett 438:1–5

    Article  CAS  PubMed  Google Scholar 

  • Zhang Y, Wang Y, Wang L, Bai M, Zhang X, Zhu X (2015) Dopamine receptor D2 and associated microRNAs are involved in stress susceptibility and resistance to escitalopram treatment. Int J Neuropsychopharmacol 18:pyv025

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors gratefully acknowledge Science and Research Branch, Islamic Azad University, for providing laboratory.

Funding

No funding was obtained for this study.

Author information

Author notes

  1. Ali Molaei and Mohadeseh Agahi contributed equally to this work.

Authors and Affiliations

  1. Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran

    Ali Molaei, Mohadeseh Agahi, Mahtash Malekian, Bahareh Moradhasel, Ardalan Tajrezaee, Ava Lajevardi, Iman Salahshourifar, Gholamreza Javadi & Zahra Noormohammadi

  2. Department of Psychiatry, School of Medicine, Imam Hossein Educational Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Niloufar Mahdavi Hezaveh

Authors
  1. Ali Molaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohadeseh Agahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahtash Malekian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bahareh Moradhasel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ardalan Tajrezaee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ava Lajevardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Iman Salahshourifar
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Niloufar Mahdavi Hezaveh
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Gholamreza Javadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Zahra Noormohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AM, MA, MM, AL, BM, and AT collected the samples and performed the PCR tests, ZN conceptualization of the project and data analyzed and interpreted. IS and GhJ data analyzed and interpreted. NMH was co-advisor and psychiatrist regards to diagnose patients. All authors were contributors in writing the manuscript and read and approved the final manuscript.

Corresponding author

Correspondence to Zahra Noormohammadi.

Ethics declarations

Ethics approval and consent to participate

The written informed consent was obtained from members of the case and control groups or their supervisors. This study was approved by the Ethical committee of Islamic Azad University, Science and Research Branch, Tehran (approval No. IR.IAU.SRB.REC.1396.43). Informed consent was obtained from patients before commencement of the research. The authors confirm that the present manuscript has not been published or submitted for publication elsewhere.

Consent for publication

The statement of consent to publish from the patient is not applicable. All authors agree to publish research findings. They guarantee that the research findings have not been previously published.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1

. Demographic characters: sex, job and age. Table S2. Demographic characters: drug usage, family history and education. Table S3. Demographic characters: alcohol usage, response to treatment and Ethnics.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Molaei, A., Agahi, M., Malekian, M. et al. A new aspect on the correlation of ten SNPs in MIR and their target genes in dopaminergic pathways in schizophrenia. Bull Natl Res Cent 46, 51 (2022). https://doi.org/10.1186/s42269-022-00744-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s42269-022-00744-w

Keywords